12/12/2018
3:13 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
12/06/2018
3:34 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
3:30 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
3:27 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
8:13 AM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2018
3:11 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
3:02 PM | BioCryst Pharmaceuticals (Issuer)
Erck Stanley C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2018
3:22 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2018
3:19 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
3:51 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
3:48 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2018
6:29 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2018
3:14 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
3:11 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
10:47 AM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/08/2018
2:15 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2018
3:05 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2018
3:03 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
3:07 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
3:04 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
7:20 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2018
12:17 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2018
8:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2018
12:34 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2018
12:31 PM | BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2018
12:09 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2018
3:25 PM | BioCryst Pharmaceuticals (Filer)
| Form DEF 14A
| |
09/18/2018
3:00 PM | BioCryst Pharmaceuticals (Filer)
| Form PRE 14A
| |
09/17/2018
6:41 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2018
6:55 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2018
12:00 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K/A
| |
09/04/2018
6:28 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2018
9:07 AM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2018
1:19 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2018
6:31 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2018
3:30 PM | BioCryst Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
08/06/2018
11:10 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2018
7:00 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2018
3:02 PM | BioCryst Pharmaceuticals (Filer)
| Form 424B5
| |
07/31/2018
3:00 PM | BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13D/A
| |
07/20/2018
2:49 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2018
7:11 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2018
3:18 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2018
2:59 PM | BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A
| |
06/22/2018
8:40 AM | BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2018
8:38 AM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2018
8:35 AM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2018
8:32 AM | BioCryst Pharmaceuticals (Issuer)
Erck Stanley C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2018
8:29 AM | BioCryst Pharmaceuticals (Issuer)
Cohen Fred E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2018
8:25 AM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2018
5:06 AM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
06/20/2018
8:53 PM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
06/20/2018
4:12 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2018
3:14 PM | BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13D/A
| |
06/11/2018
1:42 PM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
06/11/2018
1:41 PM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
06/07/2018
7:17 AM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
06/07/2018
7:15 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
06/06/2018
1:49 PM | BioCryst Pharmaceuticals (Filer)
| Form CT ORDER
| |
06/05/2018
2:07 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2018
6:42 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
06/04/2018
1:54 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2018
1:48 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2018
4:11 PM | BioCryst Pharmaceuticals (Filer)
| Form DEFM14A
| |
05/24/2018
3:00 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2018
8:31 AM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2018
8:25 AM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2018
3:06 PM | BioCryst Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/10/2018
3:06 PM | BioCryst Pharmaceuticals (Filer)
| Form DEF 14A
| |
05/09/2018
1:10 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2018
5:35 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
05/08/2018
2:15 PM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
05/08/2018
2:14 PM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
05/08/2018
7:48 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2018
7:33 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2018
7:31 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
04/10/2018
7:31 AM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
04/02/2018
4:04 PM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
04/02/2018
4:04 PM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
04/02/2018
3:52 PM | BioCryst Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D
| |
04/02/2018
11:59 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
04/02/2018
11:58 AM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
03/29/2018
2:40 PM | BioCryst Pharmaceuticals (Filer)
| Form DEFM14A
| |
03/27/2018
10:50 AM | BioCryst Pharmaceuticals (Filer)
| Form 10-K/A
| |
03/22/2018
3:06 PM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
03/22/2018
3:06 PM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
03/15/2018
8:25 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2018
1:51 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2018
4:16 PM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
03/08/2018
2:48 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2018
1:23 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2018
1:21 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2018
1:14 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2018
1:11 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2018
10:11 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
02/28/2018
7:31 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2018
11:28 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
02/27/2018
11:26 AM | BioCryst Pharmaceuticals (Subject)
| Form 425
| |
02/27/2018
7:30 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2018
7:01 AM | BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
| Form 425
| |
